TP53 and B-cell chronic lymphocytic leukemia: One study verified the feasibility of using nanopore sequencing to detect P53 gene mutations in chronic lymphocytic leukemia (CLL) patients and found that its accuracy reached 95–96% after correction by computer methods.27